Reports - Prenatal Genetic Testing Market
HealthcarePrenatal Genetic Testing Market
Prenatal Genetic Testing Market Size & Share | Growth Analysis 2035 by Technology (Diagnostics Methods, Polymerase Chain Reaction, Array Comparative Genomic Hybridization (Acgh), Fluorescence In Situ Hybridization (FISH), Screening Methods, Non-Invasive Prenatal Tests, Maternal Serum Screening) by Screening Techniques (Carrier Screening, Sequential Screening, Maternal Serum Quad Screening) by Diseases (Alzheimers Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntingtons Disease, Rare Diseases, Other Diseases) by End User (Hospitals, Clinics, Diagnostic Centers) by Product (Consumables, Assay Kits & Reagents, Disposables Instruments, Next Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Ultrasound Devices, Other Instruments) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Prenatal Genetic Testing Market - Segment Analysis
1. Overview
2. Global Prenatal Genetic Testing Market, 2021 - 2035 (USD Million)
3. Global Prenatal Genetic Testing Market - by Technology
3.1. By Diagnostics Methods
3.2. By Polymerase Chain Reaction
3.3. By Array Comparative Genomic Hybridization (Acgh)
3.4. By Fluorescence In Situ Hybridization (FISH)
3.5. By Screening Methods
3.6. By Non-Invasive Prenatal Tests
3.7. By Maternal Serum Screening
4. Global Prenatal Genetic Testing Market - by Screening Techniques
4.1. By Carrier Screening
4.2. By Sequential Screening
4.3. By Maternal Serum Quad Screening
5. Global Prenatal Genetic Testing Market - by Diseases
5.1. By Alzheimers Disease
5.2. By Cancer
5.3. By Cystic Fibrosis
5.4. By Sickle Cell Anemia
5.5. By Duchenne Muscular Dystrophy
5.6. By Thalassemia
5.7. By Huntingtons Disease
5.8. By Rare Diseases
5.9. By Other Diseases
6. Global Prenatal Genetic Testing Market - by End User
6.1. By Hospitals
6.2. By Clinics
6.3. By Diagnostic Centers
7. Global Prenatal Genetic Testing Market - by Product
7.1. By Consumables
7.2. By Assay Kits & Reagents
7.3. By Disposables Instruments
7.4. By Next Generation Sequencing Systems
7.5. By Polymerase Chain Reaction Instruments
7.6. By Microarrays
7.7. By Ultrasound Devices
7.8. By Other Instruments
8. Global Prenatal Genetic Testing Market - by region
8.1. North America
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Market comparative analysis
Chapter 4 North America Prenatal Genetic Testing Market - Segment Analysis
1. Overview
2. North America Prenatal Genetic Testing Market, 2021 - 2035 (USD Million)
3. North America Prenatal Genetic Testing Market - by Technology
3.1. By Diagnostics Methods
3.2. By Polymerase Chain Reaction
3.3. By Array Comparative Genomic Hybridization (Acgh)
3.4. By Fluorescence In Situ Hybridization (FISH)
3.5. By Screening Methods
3.6. By Non-Invasive Prenatal Tests
3.7. By Maternal Serum Screening
4. North America Prenatal Genetic Testing Market - by Screening Techniques
4.1. By Carrier Screening
4.2. By Sequential Screening
4.3. By Maternal Serum Quad Screening
5. North America Prenatal Genetic Testing Market - by Diseases
5.1. By Alzheimers Disease
5.2. By Cancer
5.3. By Cystic Fibrosis
5.4. By Sickle Cell Anemia
5.5. By Duchenne Muscular Dystrophy
5.6. By Thalassemia
5.7. By Huntingtons Disease
5.8. By Rare Diseases
5.9. By Other Diseases
6. North America Prenatal Genetic Testing Market - by End User
6.1. By Hospitals
6.2. By Clinics
6.3. By Diagnostic Centers
7. North America Prenatal Genetic Testing Market - by Product
7.1. By Consumables
7.2. By Assay Kits & Reagents
7.3. By Disposables Instruments
7.4. By Next Generation Sequencing Systems
7.5. By Polymerase Chain Reaction Instruments
7.6. By Microarrays
7.7. By Ultrasound Devices
7.8. By Other Instruments
Chapter 5 Europe Prenatal Genetic Testing Market - Segment Analysis
1. Overview
2. Europe Prenatal Genetic Testing Market, 2021 - 2035 (USD Million)
3. Europe Prenatal Genetic Testing Market - by Technology
3.1. By Diagnostics Methods
3.2. By Polymerase Chain Reaction
3.3. By Array Comparative Genomic Hybridization (Acgh)
3.4. By Fluorescence In Situ Hybridization (FISH)
3.5. By Screening Methods
3.6. By Non-Invasive Prenatal Tests
3.7. By Maternal Serum Screening
4. Europe Prenatal Genetic Testing Market - by Screening Techniques
4.1. By Carrier Screening
4.2. By Sequential Screening
4.3. By Maternal Serum Quad Screening
5. Europe Prenatal Genetic Testing Market - by Diseases
5.1. By Alzheimers Disease
5.2. By Cancer
5.3. By Cystic Fibrosis
5.4. By Sickle Cell Anemia
5.5. By Duchenne Muscular Dystrophy
5.6. By Thalassemia
5.7. By Huntingtons Disease
5.8. By Rare Diseases
5.9. By Other Diseases
6. Europe Prenatal Genetic Testing Market - by End User
6.1. By Hospitals
6.2. By Clinics
6.3. By Diagnostic Centers
7. Europe Prenatal Genetic Testing Market - by Product
7.1. By Consumables
7.2. By Assay Kits & Reagents
7.3. By Disposables Instruments
7.4. By Next Generation Sequencing Systems
7.5. By Polymerase Chain Reaction Instruments
7.6. By Microarrays
7.7. By Ultrasound Devices
7.8. By Other Instruments
Chapter 6 Asia Pacific Prenatal Genetic Testing Market - Segment Analysis
1. Overview
2. Asia Pacific Prenatal Genetic Testing Market, 2021 - 2035 (USD Million)
3. Asia Pacific Prenatal Genetic Testing Market - by Technology
3.1. By Diagnostics Methods
3.2. By Polymerase Chain Reaction
3.3. By Array Comparative Genomic Hybridization (Acgh)
3.4. By Fluorescence In Situ Hybridization (FISH)
3.5. By Screening Methods
3.6. By Non-Invasive Prenatal Tests
3.7. By Maternal Serum Screening
4. Asia Pacific Prenatal Genetic Testing Market - by Screening Techniques
4.1. By Carrier Screening
4.2. By Sequential Screening
4.3. By Maternal Serum Quad Screening
5. Asia Pacific Prenatal Genetic Testing Market - by Diseases
5.1. By Alzheimers Disease
5.2. By Cancer
5.3. By Cystic Fibrosis
5.4. By Sickle Cell Anemia
5.5. By Duchenne Muscular Dystrophy
5.6. By Thalassemia
5.7. By Huntingtons Disease
5.8. By Rare Diseases
5.9. By Other Diseases
6. Asia Pacific Prenatal Genetic Testing Market - by End User
6.1. By Hospitals
6.2. By Clinics
6.3. By Diagnostic Centers
7. Asia Pacific Prenatal Genetic Testing Market - by Product
7.1. By Consumables
7.2. By Assay Kits & Reagents
7.3. By Disposables Instruments
7.4. By Next Generation Sequencing Systems
7.5. By Polymerase Chain Reaction Instruments
7.6. By Microarrays
7.7. By Ultrasound Devices
7.8. By Other Instruments
Chapter 7 Latin America Prenatal Genetic Testing Market - Segment Analysis
1. Overview
2. Latin America Prenatal Genetic Testing Market, 2021 - 2035 (USD Million)
3. Latin America Prenatal Genetic Testing Market - by Technology
3.1. By Diagnostics Methods
3.2. By Polymerase Chain Reaction
3.3. By Array Comparative Genomic Hybridization (Acgh)
3.4. By Fluorescence In Situ Hybridization (FISH)
3.5. By Screening Methods
3.6. By Non-Invasive Prenatal Tests
3.7. By Maternal Serum Screening
4. Latin America Prenatal Genetic Testing Market - by Screening Techniques
4.1. By Carrier Screening
4.2. By Sequential Screening
4.3. By Maternal Serum Quad Screening
5. Latin America Prenatal Genetic Testing Market - by Diseases
5.1. By Alzheimers Disease
5.2. By Cancer
5.3. By Cystic Fibrosis
5.4. By Sickle Cell Anemia
5.5. By Duchenne Muscular Dystrophy
5.6. By Thalassemia
5.7. By Huntingtons Disease
5.8. By Rare Diseases
5.9. By Other Diseases
6. Latin America Prenatal Genetic Testing Market - by End User
6.1. By Hospitals
6.2. By Clinics
6.3. By Diagnostic Centers
7. Latin America Prenatal Genetic Testing Market - by Product
7.1. By Consumables
7.2. By Assay Kits & Reagents
7.3. By Disposables Instruments
7.4. By Next Generation Sequencing Systems
7.5. By Polymerase Chain Reaction Instruments
7.6. By Microarrays
7.7. By Ultrasound Devices
7.8. By Other Instruments
Chapter 8 Middle East & Africa Prenatal Genetic Testing Market - Segment Analysis
1. Overview
2. Middle East & Africa Prenatal Genetic Testing Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Prenatal Genetic Testing Market - by Technology
3.1. By Diagnostics Methods
3.2. By Polymerase Chain Reaction
3.3. By Array Comparative Genomic Hybridization (Acgh)
3.4. By Fluorescence In Situ Hybridization (FISH)
3.5. By Screening Methods
3.6. By Non-Invasive Prenatal Tests
3.7. By Maternal Serum Screening
4. Middle East & Africa Prenatal Genetic Testing Market - by Screening Techniques
4.1. By Carrier Screening
4.2. By Sequential Screening
4.3. By Maternal Serum Quad Screening
5. Middle East & Africa Prenatal Genetic Testing Market - by Diseases
5.1. By Alzheimers Disease
5.2. By Cancer
5.3. By Cystic Fibrosis
5.4. By Sickle Cell Anemia
5.5. By Duchenne Muscular Dystrophy
5.6. By Thalassemia
5.7. By Huntingtons Disease
5.8. By Rare Diseases
5.9. By Other Diseases
6. Middle East & Africa Prenatal Genetic Testing Market - by End User
6.1. By Hospitals
6.2. By Clinics
6.3. By Diagnostic Centers
7. Middle East & Africa Prenatal Genetic Testing Market - by Product
7.1. By Consumables
7.2. By Assay Kits & Reagents
7.3. By Disposables Instruments
7.4. By Next Generation Sequencing Systems
7.5. By Polymerase Chain Reaction Instruments
7.6. By Microarrays
7.7. By Ultrasound Devices
7.8. By Other Instruments
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Abbott (U.S.)
2. Siemens Healthineers AG (Germany)
3. Quidel Corporation (U.S.)
4. F. Hoffman-La Roche Ltd. (Switzerland)
5. Danaher. (U.S.)
6. B.D. (U.S.)
7. Chembio Diagnostics (U.S.)
8. Trinity Biotech plc (Ireland)
9. Instrumentation Laboratory (U.S.)
10. Nova Biomedical (U.S.)
11. PTS Diagnostics (U.S.)
12. Sekisui Diagnostics (U.S.)
13. Thermo Fisher Scientific (U.S.)
14. DiaSorin S.p.A (Italy)
15. AccuBioTech Co. Ltd. (China)
16. Meridian Bioscience (U.S.)
17. GeneSTAT Molecular Diagnostics
18. LLC (U.S.)
19. Terumo Corporation (Japan)
20. Grifols
21. S.A (Spain)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By